Antenatal description of large 4q13.2q21.23 deletion and outcomes
Molecular Genetics & Genomic Medicine · 2024
DOI: 10.1002/mgg3.2397 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2024. Verfasst von Anna-Gaëlle Giguet-Valard und 9 weiteren Autor:innen. Beteiligte Einrichtung: Multidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders, University Hospital Center of Martinique, Fort-de…. Hauptthemen laut MEDLINE: Chromosome Deletion, Chromosome Disorders. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
4q21 microdeletion syndrome is an emergent non‐recurrent genomic disorder characterized by facial dysmorphy, progressive growth retardation, severe intellectual deficit, and absent or severely delayed speech. Deletions occur in clusters along 4q interstitial or terminal regions. 4q chromosomal aberrations are variable in type, size, and breakpoint. Genotype–phenotype correlation is a challenging task. The recurrent antenatal feature associated a posteriori with this syndrome is intrauterine growth retardation. There are very few precise antenatal descriptions of this syndrome.
Methods
We report here the first antenatal history of one of the largest deletion of this region.
Results
Our case harbored a 16.9 Mb deletion encompassing 135 protein coding genes including 20 OMIM morbid genes involved in neurological and cognitive abilities. Those breakpoints overlap two clusters of described microdeletion syndromes of cytogenetic band 4q13 and 4q21.
Conclusion
From the end of the second trimester, set of call signs associated with this syndrome can be completed by: excess of amniotic fluid, mild growth retardation, short long bones, bony anomalies of the extremities, and bulging cheeks. So, emphasis should be placed on the examination of the extremities, and the face during the routine targeted prenatal ultrasound.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Multidisciplinary Department for Antenatal Diagnosis/Rare Neurological and Neuromuscular Disorders, University Hospital Center of Martinique, Fort-de-France, France.
- Private Laboratory for Biological Tests - BIOLAB Martinique, Fort-de-France, France.
- Pre-Natal Biochemistry Unit, Biochemistry-Hormonology Laboratory, Robert Debré Hospital, DMU Biogem AP-HP, Paris, France.
- Radiology Department, University Hospital Center of Martinique, Fort-de-France, France.
- Genomic Laboratory, University Hospital of Necker, Paris, France.
ORCID-Profile: Anna-Gaëlle Giguet-Valard, Sophie Dreux
Zitieren
APA
Giguet-Valard, A. G., Thevenin, C., Dreux, S., Decatrelle, V., Juve, M. L., Yazza, S., Adenet, C., Lesueur, M., Bouvagnet, P., & Gueneret, M. (2024). Antenatal description of large 4q13.2q21.23 deletion and outcomes. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2397
Vancouver
Giguet-Valard AG, Thevenin C, Dreux S, Decatrelle V, Juve ML, Yazza S, et al. Antenatal description of large 4q13.2q21.23 deletion and outcomes. Molecular Genetics & Genomic Medicine. 2024. doi:10.1002/mgg3.2397
BibTeX
@article{GiguetValard2024,
author = {Giguet-Valard, Anna-Gaëlle and Thevenin, Christelle and Dreux, Sophie and Decatrelle, Valérie and Juve, Marie-Laure and Yazza, Soraya and Adenet, Clara and Lesueur, Marion and Bouvagnet, Patrice and Gueneret, Michèle},
title = {Antenatal description of large 4q13.2q21.23 deletion and outcomes},
journal = {Molecular Genetics & Genomic Medicine},
year = {2024},
doi = {10.1002/mgg3.2397}
}
EUVIMED